Home > Healthcare > Medical Devices > Diagnostic Devices > In-vitro Toxicology Testing Market

In-vitro Toxicology Testing Market Share

  • Report ID: GMI5543
  • Published Date: Feb 2024
  • Report Format: PDF

In-vitro Toxicology Testing Market Share

The in-vitro toxicology testing industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. Some of the leading industry players including Abbott Laboratories, Inc., Merck KGaA, Danaher Corporation among others have a notable presence in the market. These companies compete based on factors such as product portfolio breadth, technological innovation, pricing strategies, and geographical presence. Additionally, partnerships, collaborations, and acquisitions are common strategies employed by players to strengthen their market position and expand their customer base.
 

In-vitro Toxicology Testing Market Companies

Some of the eminent market participants operating in the in-vitro toxicology testing industry include:

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • Evotec S.E.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Quest Diagnostics Incorporated
  • SGS Societe Generale de Surveillance SA
  • Thermo Fisher Scientific Inc.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

In-vitro toxicology testing industry reached USD 1.9 billion in revenue in 2023 and is projected to surpass USD 3.6 billion by 2032 attributed to increasing incorporation in drug development and product safety assessment processes by pharmaceutical and cosmetics companies.

The cell culture technology segment is poised for significant growth at 7.8% CAGR during 2024-2032 attributed to the increasing use of organoids, which are three-dimensional, miniature organs grown in vitro.

North America in-vitro toxicology testing market generated USD 857.2 million in revenue in 2023 and is set to exhibit robust growth through 2032 driven by the notable trend toward the increased adoption of in-vitro testing methods as an alternative to traditional animal testing.

Some of the top firms engaged in the in-vitro toxicology testing industry are Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Catalent, Inc., Danaher Corporation, Eurofins Scientific, Evotec S.E., Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc., among others.

In-vitro Toxicology Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 417
  • Countries covered: 22
  • Pages: 270
 Download Free Sample